A detailed history of Capital Market Strategies LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital Market Strategies LLC holds 9,843 shares of NVO stock, worth $1.4 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
9,843
Previous 9,164 7.41%
Holding current value
$1.4 Million
Previous $948,000 33.23%
% of portfolio
1.0%
Previous 0.84%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

BUY
$102.11 - $135.92 $69,332 - $92,289
679 Added 7.41%
9,843 $1.26 Million
Q4 2023

Jan 08, 2024

BUY
$87.78 - $105.45 $101,649 - $122,111
1,158 Added 14.46%
9,164 $948,000
Q3 2023

Oct 18, 2023

BUY
$90.94 - $199.54 $424,144 - $930,654
4,664 Added 139.56%
8,006 $728,000
Q2 2023

Jul 06, 2023

BUY
$155.98 - $172.65 $521,285 - $576,996
3,342 New
3,342 $540,000
Q4 2022

Jan 17, 2023

BUY
$102.55 - $135.33 $197,408 - $260,510
1,925 New
1,925 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Capital Market Strategies LLC Portfolio

Follow Capital Market Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Market Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Market Strategies LLC with notifications on news.